183 related articles for article (PubMed ID: 23606272)
1. CD39 is involved in mediating suppression by Mycobacterium bovis BCG-activated human CD8(+) CD39(+) regulatory T cells.
Boer MC; van Meijgaarden KE; Bastid J; Ottenhoff TH; Joosten SA
Eur J Immunol; 2013 Jul; 43(7):1925-32. PubMed ID: 23606272
[TBL] [Abstract][Full Text] [Related]
2. CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis.
Fletcher JM; Lonergan R; Costelloe L; Kinsella K; Moran B; O'Farrelly C; Tubridy N; Mills KH
J Immunol; 2009 Dec; 183(11):7602-10. PubMed ID: 19917691
[TBL] [Abstract][Full Text] [Related]
3. Surface expression of CD39 identifies an enriched Treg-cell subset in the rheumatic joint, which does not suppress IL-17A secretion.
Herrath J; Chemin K; Albrecht I; Catrina AI; Malmström V
Eur J Immunol; 2014 Oct; 44(10):2979-89. PubMed ID: 24990235
[TBL] [Abstract][Full Text] [Related]
4. IL-12 and IL-4 activate a CD39-dependent intrinsic peripheral tolerance mechanism in CD8(+) T cells.
Noble A; Mehta H; Lovell A; Papaioannou E; Fairbanks L
Eur J Immunol; 2016 Jun; 46(6):1438-48. PubMed ID: 26990545
[TBL] [Abstract][Full Text] [Related]
5. CD8+ regulatory T cells, and not CD4+ T cells, dominate suppressive phenotype and function after in vitro live Mycobacterium bovis-BCG activation of human cells.
Boer MC; van Meijgaarden KE; Joosten SA; Ottenhoff TH
PLoS One; 2014; 9(4):e94192. PubMed ID: 24714620
[TBL] [Abstract][Full Text] [Related]
6. Extracorporeal photophoresis augments function of CD4+CD25+FoxP3+ regulatory T cells by triggering adenosine production.
Schmitt S; Johnson TS; Karakhanova S; Näher H; Mahnke K; Enk AH
Transplantation; 2009 Aug; 88(3):411-6. PubMed ID: 19667946
[TBL] [Abstract][Full Text] [Related]
7. Low expression of CD39(+) /CD45RA(+) on regulatory T cells (Treg ) cells in type 1 diabetic children in contrast to high expression of CD101(+) /CD129(+) on Treg cells in children with coeliac disease.
Åkesson K; Tompa A; Rydén A; Faresjö M
Clin Exp Immunol; 2015 Apr; 180(1):70-82. PubMed ID: 25421756
[TBL] [Abstract][Full Text] [Related]
8. Bacille Calmette-Guérin vaccination enhances human gamma delta T cell responsiveness to mycobacteria suggestive of a memory-like phenotype.
Hoft DF; Brown RM; Roodman ST
J Immunol; 1998 Jul; 161(2):1045-54. PubMed ID: 9670986
[TBL] [Abstract][Full Text] [Related]
9. Diminished levels of regulatory T cell subsets (CD8+Foxp3, CD4+Foxp3 and CD4+CD39+Foxp3) but increased Foxp3 expression in adipose tissue from overweight subjects.
Núñez Ruiz A; Cortés-Garcia JD; Cortez-Espinosa N; Herrera-Rojas PI; Ruíz-Rodríguez VM; Salgado-Bustamante M; García-Hernández MH; Reynaga-Hernández E; Martínez-Jimenez Vdel C; Portales-Pérez DP
Nutrition; 2016 Sep; 32(9):943-54. PubMed ID: 27160497
[TBL] [Abstract][Full Text] [Related]
10. CD39 is highly involved in mediating the suppression activity of tumor-infiltrating CD8+ T regulatory lymphocytes.
Parodi A; Battaglia F; Kalli F; Ferrera F; Conteduca G; Tardito S; Stringara S; Ivaldi F; Negrini S; Borgonovo G; Simonato A; Traverso P; Carmignani G; Fenoglio D; Filaci G
Cancer Immunol Immunother; 2013 May; 62(5):851-62. PubMed ID: 23359087
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of CD39 enzymatic function at the surface of tumor cells alleviates their immunosuppressive activity.
Bastid J; Regairaz A; Bonnefoy N; Déjou C; Giustiniani J; Laheurte C; Cochaud S; Laprevotte E; Funck-Brentano E; Hemon P; Gros L; Bec N; Larroque C; Alberici G; Bensussan A; Eliaou JF
Cancer Immunol Res; 2015 Mar; 3(3):254-65. PubMed ID: 25403716
[TBL] [Abstract][Full Text] [Related]
12. The CD39 molecule defines distinct cytotoxic subsets within alloactivated human CD8-positive cells.
Gouttefangeas C; Mansur I; Schmid M; Dastot H; Gélin C; Mahouy G; Boumsell L; Bensussan A
Eur J Immunol; 1992 Oct; 22(10):2681-5. PubMed ID: 1396972
[TBL] [Abstract][Full Text] [Related]
13. Increased frequency of CD4(+)CD25(high) Treg cells inhibit BCG-specific induction of IFN-gamma by CD4(+) T cells from TB patients.
Li L; Lao SH; Wu CY
Tuberculosis (Edinb); 2007 Nov; 87(6):526-34. PubMed ID: 17851131
[TBL] [Abstract][Full Text] [Related]
14. CD39 is upregulated during activation of mouse and human T cells and attenuates the immune response to Listeria monocytogenes.
Raczkowski F; Rissiek A; Ricklefs I; Heiss K; Schumacher V; Wundenberg K; Haag F; Koch-Nolte F; Tolosa E; Mittrücker HW
PLoS One; 2018; 13(5):e0197151. PubMed ID: 29742141
[TBL] [Abstract][Full Text] [Related]
15. Accelerating the secondary immune response by inactivating CD4(+)CD25(+) T regulatory cells prior to BCG vaccination does not enhance protection against tuberculosis.
Quinn KM; Rich FJ; Goldsack LM; de Lisle GW; Buddle BM; Delahunt B; Kirman JR
Eur J Immunol; 2008 Mar; 38(3):695-705. PubMed ID: 18266274
[TBL] [Abstract][Full Text] [Related]
16. Foxp3(high) and Foxp3(low) Treg cells differentially correlate with T helper 1 and natural killer cells in peripheral blood.
Lee SK; Kim JY; Jang BW; Hur SE; Na BJ; Lee M; Fukui A; Gilman-Sachs A; Kwak-Kim J
Hum Immunol; 2011 Aug; 72(8):621-6. PubMed ID: 21600259
[TBL] [Abstract][Full Text] [Related]
17. Separation of human CD4+CD39+ T cells by magnetic beads reveals two phenotypically and functionally different subsets.
Schuler PJ; Harasymczuk M; Schilling B; Lang S; Whiteside TL
J Immunol Methods; 2011 Jun; 369(1-2):59-68. PubMed ID: 21513715
[TBL] [Abstract][Full Text] [Related]
18. TLR2 agonists enhance CD8+Foxp3+ regulatory T cells and suppress Th2 immune responses during allergen immunotherapy.
Tsai YG; Yang KD; Niu DM; Chien JW; Lin CY
J Immunol; 2010 Jun; 184(12):7229-37. PubMed ID: 20483759
[TBL] [Abstract][Full Text] [Related]
19. Regulatory T cells negatively affect IL-2 production of effector T cells through CD39/adenosine pathway in HIV infection.
Jenabian MA; Seddiki N; Yatim A; Carriere M; Hulin A; Younas M; Ghadimi E; Kök A; Routy JP; Tremblay A; Sévigny J; Lelievre JD; Levy Y
PLoS Pathog; 2013; 9(4):e1003319. PubMed ID: 23658513
[TBL] [Abstract][Full Text] [Related]
20. iTreg induced from CD39(+) naive T cells demonstrate enhanced proliferate and suppressive ability.
Lu Y; Wang X; Gu J; Lu H; Zhang F; Li X; Qian X; Wang X; Lu L
Int Immunopharmacol; 2015 Oct; 28(2):925-30. PubMed ID: 25864618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
